Author:
Dehghani Bijan,Rodeo Scott
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference85 articles.
1. Brook P. The burden of musculoskeletal disease – a global perspective. Clin Rheumatol. 2006;25:778–81.
2. Fralinger DJ, Kaplan DJ, Weinberg ME, Strauss EJ, Jazrawi LM. Biological treatments for tendon and ligament abnormalities: a critical analysis review. JBJS Rev. 2016;4(6). doi: 10.2106/JBJS.RVW.15.00079
3. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44(8):1928–42.
4. •• Food and Drug Administration USDoHaHS. Regulatory Considerations for Human Cells, Tissues and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. In: Research USDoHaHSFaDACfBEa, ed; 2017. This reference lays the foundation for regulatory environment surrounding cell therapy in the United States.
5. Chirba MA, Sweetapple B, Hannon CP, Anderson JA. FDA regulation of adult stem cell therapies as used in sports medicine. J Knee Surg. 2015;28(01):055–62.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献